Conquer Cancer, Pfizer collaborate to advance equitable care of patients with metastatic breast cancer

Call for applications: Equitable Care of Metastatic Breast Cancer Patients

ALEXANDRIA, Virginia (June 4. 2021) – Conquer Cancer, the ASCO Foundation, today announced a collaboration with Pfizer Global Medical Grants to support research to promote and advance scientific knowledge concerning equitable care of patients with metastatic breast cancer (mBC).

Equitable Care of Metastatic Breast Cancer (mBC) Patients: A Phased Approach to Understanding and Addressing Healthcare Disparities for People of Color is a grant program which will award funding to selected proposals that employ data-driven frameworks to define and address inequities in the delivery of patient care and outcomes. 

This competitive research grant program is part of Pfizer’s commitment to eliminate the health disparities in metastatic breast cancer care. Successful applicants to this program will be expected to share their findings with the oncology community through a future grantee meeting to be convened by Conquer Cancer in late 2022. Grant recipients also will be invited to compete for additional grant funding Pfizer anticipates providing in early 2023 to implement any of the potential solutions to the care disparities uncovered during the initial project term.

“Achieving health equity for cancer care requires the entire oncology community. Conquer Cancer is pleased to support the work and the significant research investment being made by Pfizer to address equity in the metastatic breast cancer population,” said Nancy R. Daly, MS, MPH, CEO of Conquer Cancer.

Pfizer will invest up to $1.5 million dollars to fund approximately 10, one-year data-driven research projects to define and address inequities in the delivery of patient care and outcomes within a given healthcare delivery system.  Applications are being accepted now until August 4, 2021.

Conquer Cancer is the lead organization for the review and evaluation of grant applications. Only US-based organizations are eligible to receive grants. Principal investigators from eligible institutions, which include academic cancer centers, health care delivery networks, and large community cancer centers or hospitals, must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work. Individuals or physician-owned medical group practices are not eligible to receive grants. Grant funding will be provided directly from Pfizer. 

Please click here for more information. To apply, click here. For questions, please contact